By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic gene developer DNA 2.0 said today that it will use a grant from the National Science Foundation to continue to advance its synthetic biology technologies, with a specific focus on mammalian cells.

The firm plans to use the Small Business Innovation Research award to extend its gene optimization algorithms for protein expression, which is used in producing hosts for human therapeutics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.